MalariaWorld Events's blog
The Second Global Malaria Action Plan (GMAP2) will cover the timeframe 2016-2025.
You are strongly encouraged to have a look and contribute by sharing your vision for a malaria-free world.
Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.
Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV.
Dear Sir or Madam
The Pan African Mosquito Control Association (PAMCA) is a professional body comprised of mosquito control and research professionals from Africa and beyond. The overall objective of the organization is to promote control of and research on mosquitoes and to disseminate information on the bionomics of mosquitoes and related subjects across Africa and worldwide. PAMCA is organising its first Annual Conference in Nairobi from 6 to 8 October 2014 at Panari Hotel.
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
6 October 2013: Career opportunities for African Malaria Researchers
9 October 2013: Woman and Science Breakfast Seminar
Major success in the fight against malaria has largely been due to efforts aimed at killing mosquitoes. The targeted attack has involved deployment of bed nets and indoor sprays that include insecticides. But mosquitoes are developing resistance to these chemicals while at the same time global funds for their deployment are shrinking. In the push towards global elimination of malaria, we need to get smarter in the way we wage war against our six-legged enemy.